Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Good morning. This is our last newsletter of the year! We’re taking a break but we’ll be back on Monday, Jan. 5. In the meantime, hope you all enjoy the holidays, eat lots, and sleep lots.
Drugmakers and PBMs still don’t have to publish net prices
Under a rule proposed by the Trump administration, pharma companies and pharmacy benefit managers will still not have to post the actual prices paid for prescription drugs, more than five years after federal law required them to do so.
Continue to STAT+ to read the full story…